MarketPeel
Insider Trading Intelligence
Pricing
…
ME

Manner Carrie Eglinton

DGX
SVP, ADVANCED DIAGNOSTICS · QUEST DIAGNOSTICS INC · CIK 0001696776
FILING MIX · LIFETIME62%/38%
BUYS
36
SELLS
22
TOTAL VALUE
$17.74M
COMPANIES
3
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
2,244,726
AVG SELL PX
$7.80
TRADE KIND
SHOWING 58 / 58
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 8 pending
Forward-return performance of every backtestable P/S trade by Manner Carrie Eglinton, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+71.43%-1.29%-1.39%+0.10%+1.40%—
14d7+100.00%+1.72%-0.68%+2.39%+3.29%—
30d7+71.43%+0.81%+2.12%-1.31%-1.14%—
60d7+28.57%-5.93%+0.26%-7.10%-9.09%—
90d7+28.57%+7.83%+5.20%+2.62%-5.69%—
180d7(2 pending)+40.00%+11.71%+11.55%+0.16%-10.83%—
1y7(2 pending)+20.00%+4.34%+24.28%-19.94%-25.28%—
2y7(4 pending)+33.33%+17.43%+40.14%-22.71%-26.66%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
DGX · 48,391 shares · as of Mar 7, 2022
014,08528,16942,25456,33820212022SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 36 buys / 22 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
995——5,461May 14, 2026May 18, 2026 ↗View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
2,239——2,239May 14, 2026May 18, 2026 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
PURCHASE10b5-1
10b5-1 plan
32,300$2.93$94.6K2,190,874Mar 20, 2026Mar 23, 2026 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
PURCHASE10b5-1
10b5-1 plan
22,022$3.00$66.0K2,158,574Mar 13, 2026Mar 16, 2026 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
PURCHASEGRANT
Stock grant
355,464——2,136,552Mar 2, 2026Mar 3, 2026 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
SALE
President & CEO
56,116$3.04$170.7K1,903,743Mar 1, 2026Mar 3, 2026 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
SALE
President & CEO
122,655$3.04$373.2K1,781,088Mar 1, 2026Mar 3, 2026 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
PURCHASEGRANT
Stock grant
129,032——1,959,859Mar 1, 2026Mar 3, 2026 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
SALE
President & CEO
47,249$2.90$137.0K1,830,827Jun 4, 2025Jun 5, 2025 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
SALE
President & CEO
146,000$2.90$423.4K1,878,076Jun 4, 2025Jun 5, 2025 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
PURCHASEGRANT
Stock grant
335,710——2,024,076Jun 4, 2025Jun 5, 2025 ↗View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
1,800——1,800May 15, 2025May 19, 2025 ↗View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
973——4,466May 15, 2025May 19, 2025 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
PURCHASEGRANT
Stock grant
462,414——1,750,748Mar 1, 2025Mar 4, 2025 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
SALE
President & CEO
62,382$3.63$226.3K1,688,366Mar 1, 2025Mar 4, 2025 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
PURCHASE
President & CEO
28,670$3.49$100.0K1,288,334Feb 28, 2025Mar 3, 2025 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
PURCHASE
President & CEO
78,625$3.15$247.4K1,259,664Feb 27, 2025Feb 27, 2025 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
SALE
President & CEO
401,618$4.65$1.87M1,181,039Jun 4, 2024Jun 6, 2024 ↗View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
701——3,493May 16, 2024May 20, 2024 ↗View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
1,376——1,376May 16, 2024May 20, 2024 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
SALE
President & CEO
29,647$7.19$213.2K1,582,657Mar 1, 2024Mar 5, 2024 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
PURCHASEGRANT
Stock grant
260,688——1,612,304Mar 1, 2024Mar 5, 2024 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
SALE
President & CEO
47,211$5.48$258.7K1,351,616Jun 4, 2023Jun 6, 2023 ↗View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
1,487——1,487May 18, 2023May 22, 2023 ↗View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
686——2,167May 18, 2023May 22, 2023 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
PURCHASEGRANT
Stock grant
258,065——1,398,827Mar 1, 2023Mar 3, 2023 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
PURCHASEGRANT
Stock grant
814,830$4.91$4.00M814,830Jun 4, 2022Jun 6, 2022 ↗View →
OSUR
ORASURE TECHNOLOGIES INC
PURCHASEGRANT
Stock grant
325,932$4.91$1.60M1,140,762Jun 4, 2022Jun 6, 2022 ↗View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
2,488——2,488May 26, 2022May 31, 2022 ↗View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
1,024——1,481May 26, 2022May 31, 2022 ↗View →
RGEN
REPLIGEN CORP
PURCHASE
625$175.02$109.4K2,106Mar 16, 2022Dec 15, 2022 ↗View →
DGX
QUEST DIAGNOSTICS INC
PURCHASEGRANT
Stock grant
16,162$130.09$2.10M56,338Mar 7, 2022Mar 9, 2022 ↗View →
DGX
QUEST DIAGNOSTICS INC
SALE
SVP, Advanced Diagnostics
7,947$130.09$1.03M48,391Mar 7, 2022Mar 9, 2022 ↗View →
DGX
QUEST DIAGNOSTICS INC
PURCHASEGRANT
Stock grant
19,009——19,009Feb 24, 2022Feb 28, 2022 ↗View →
DGX
QUEST DIAGNOSTICS INC
PURCHASEGRANT
Stock grant
3,915——32,346Feb 24, 2022Feb 28, 2022 ↗View →
DGX
QUEST DIAGNOSTICS INC
PURCHASEGRANT
Stock grant
7,830——40,176Feb 24, 2022Feb 28, 2022 ↗View →
DGX
QUEST DIAGNOSTICS INC
SALE
SVP, Advanced Diagnostics
1,368$130.09$178.0K28,882Feb 23, 2022Feb 25, 2022 ↗View →
DGX
QUEST DIAGNOSTICS INC
SALE
SVP, Advanced Diagnostics
609$130.23$79.3K28,431Feb 23, 2022Feb 25, 2022 ↗View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
1,151——1,151May 13, 2021May 17, 2021 ↗View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
457——457May 13, 2021May 17, 2021 ↗View →
DGX
QUEST DIAGNOSTICS INC
PURCHASEGRANT
Stock grant
13,181$115.42$1.52M36,394Mar 9, 2021Mar 11, 2021 ↗View →
DGX
QUEST DIAGNOSTICS INC
SALE
SVP, Advanced Diagnostics
6,165$115.42$711.6K30,250Mar 9, 2021Mar 11, 2021 ↗View →
DGX
QUEST DIAGNOSTICS INC
SALE
SVP, Advanced Diagnostics
611$121.19$74.0K23,213Feb 24, 2021Feb 25, 2021 ↗View →
DGX
QUEST DIAGNOSTICS INC
SALE
SVP, Advanced Diagnostics
1,017$121.15$123.2K23,824Feb 23, 2021Feb 25, 2021 ↗View →
DGX
QUEST DIAGNOSTICS INC
PURCHASEGRANT
Stock grant
4,926——24,841Feb 17, 2021Feb 19, 2021 ↗View →
DGX
QUEST DIAGNOSTICS INC
PURCHASEGRANT
Stock grant
27,633——27,633Feb 17, 2021Feb 19, 2021 ↗View →
DGX
QUEST DIAGNOSTICS INC
SALE
SVP, Advanced Diagnostics
2,640$119.00$314.2K19,896Jan 4, 2021Jan 6, 2021 ↗View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
2,794——2,794Jun 11, 2020Jun 15, 2020 ↗View →
DGX
QUEST DIAGNOSTICS INC
SALE
SVP, Advanced Diagnostics
2,500$112.03$280.1K24,890Apr 27, 2020Apr 28, 2020 ↗View →
DGX
QUEST DIAGNOSTICS INC
SALE
SVP, Advanced Diagnostics
2,500$110.00$275.0K22,390Apr 27, 2020Apr 28, 2020 ↗View →
DGX
QUEST DIAGNOSTICS INC
SALE
SVP, Advanced Diagnostics
2,517$106.46$268.0K27,390Mar 10, 2020Mar 12, 2020 ↗View →
DGX
QUEST DIAGNOSTICS INC
PURCHASEGRANT
Stock grant
5,018$106.46$534.2K29,907Mar 10, 2020Mar 12, 2020 ↗View →
DGX
QUEST DIAGNOSTICS INC
SALE
SVP, Advanced Diagnostics
773$112.90$87.3K24,889Feb 26, 2020Feb 27, 2020 ↗View →
DGX
QUEST DIAGNOSTICS INC
SALE
SVP, Advanced Diagnostics
423$113.34$47.9K25,662Feb 25, 2020Feb 26, 2020 ↗View →
DGX
QUEST DIAGNOSTICS INC
SALE
SVP, Advanced Diagnostics
515$112.17$57.8K26,085Feb 24, 2020Feb 26, 2020 ↗View →
DGX
QUEST DIAGNOSTICS INC
PURCHASEGRANT
Stock grant
34,887——34,887Feb 18, 2020Feb 20, 2020 ↗View →
DGX
QUEST DIAGNOSTICS INC
PURCHASEGRANT
Stock grant
5,350——26,600Feb 18, 2020Feb 20, 2020 ↗View →
DGX
QUEST DIAGNOSTICS INC
SALE
SVP, Advanced Diagnostics
1,543$106.52$164.4K21,250Jan 2, 2020Jan 3, 2020 ↗View →
Other insiders · DGX
Loading peer insiders…
About this filer
CIK 0001696776
ROLE
SVP, Advanced Diagnostics
PRIMARY
DGX
COMPANIES
3
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001696776DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback